Basic principles in oncology course

HYBRID EVENT

Basic principles in oncology course

HYBRID EVENT






COURSE SCIENTIFIC LEADERSHIP:

Scientific Supervisor -  B. A. Jereczek-Fossa, IT
Host Chair - S. Servais, LU
ESO College Chair - A. Eniu, RO/CH
Medical Chair - F. Cardoso, PT

Course Overview

ESO offers a comprehensive introductory course for oncology trainees in Europe, designed to bridge the gap between undergraduate education and ESO’s renowned Masterclasses.
The course provides orientation to the core principles of multidisciplinary cancer care and offers insight into the professional life of the modern oncologist.

While some foundational principles of oncology align with general medical training, increasing sub-specialisation has limited early exposure to oncological practice. As a result, new trainees often face unique challenges — from navigating a vast and complex curriculum, to adapting to a fast-evolving clinical environment, all while managing career planning, academic development, and work-life balance.

 

Learning Objectives

Participants will receive structured updates and introductions on the following topics:

  • Fundamentals of aetiology and epidemiology
  • Basics of cancer genetics, staging, and imaging
  • Essentials of surgical oncology and pathology
  • Principles of radiotherapy and chemotherapy
  • Introduction to paediatric oncology
  • Overview of tumour boards and key patient-centred issues: communication, supportive and palliative care
  • Introduction to clinical trials and critical appraisal of scientific literature

 

 

This course is endorsed by the University of Luxembourg.

 

Course Format

The course is divided into two parts:

  • Part 1 – Online Learning
    Participants will complete a series of pre-recorded lectures made available online.
    These must be completed prior to the in-person event.
  • Part 2 – In-Person Event
    Location: Luxembourg, LU
    Dates: 19–21 September 2025
    Duration: 2.5 days
 Language

The course will be held in English.
No translation services will be provided.

 

Registration Fee

Selected participants will be asked to confirm their attendance by paying a registration fee of EUR 150,00 which includes:

  • Access to the full course and its educational materials
  • 3 nights’ accommodation
  • Meals as outlined in the programme


Travel costs are not covered and must be arranged independently.

ESO College members at the time of application receive a 50% discount on the registration fee.


The fee is a non-refundable contribution towards organisational costs and will not be reimbursed in the case of withdrawal or non-attendance, regardless of the reason.

 

Accreditation

Participants must attend at least 75% of the course to receive a certificate of attendance.
To obtain the certificate, participants must also complete an online evaluation questionnaire and a learning assessment test. Certificates will be sent via email.

Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). 

ESO College Membership

Participation in this course grants eligibility to join the ESO College and allows existing members to earn 18 ESO College credits toward their progression.

Visit ESO College dedicated section for more information on membership and benefits.

 

Insurance

ESO cannot be held responsible for any personal or travel-related incidents.
Participants are strongly advised to arrange their own personal and travel insurance coverage.


Contacts – Organising Secretariat

Corinne Hall
European School of Oncology
 +39 331 6125784
chall@eso.net


Dolores Knupfer

European School of Oncology
+41 91 820 09 50
dknupfer@eso.net

 

 

Abdelkader Heddar profile photo
Abdelkader Heddar

Luxembourg Institute of Health, LuxGen Genome Center, Dudelange, LU

Alexandru Eniu profile photo
Alexandru Eniu

Genolier Cancer Center, Clinique de Genolier, Medical Oncology Dpt., Genolier, CH

Anastasia Constantinidou profile photo
Anastasia Constantinidou

Bank of Cyprus Oncology Centre and Medical School University of Cyprus, Dept. of Oncology, Nicosia, CY

Assia Konsoulova profile photo
Assia Konsoulova

National Cancer Hospital, Medical Oncology Clinic, Sofia, BG

Barbara Alicja Jereczek-fossa profile photo
Barbara Alicja Jereczek-fossa

European Institute of Oncology, Dept. of Radiotherapy, Milano, IT

Carolin Mogler profile photo
Carolin Mogler

Technical University Munich, Molecular Pathology Department, Munich, DE

Daniel Stieber profile photo
Daniel Stieber

Luxembourg Institute of Health, LuxGen Genome Center, Dudelange, LU

Danny Kupka profile photo
Danny Kupka

Freiburger Spital, HFR Kantonsspital Freiburg, Dept. of Oncology, Freiburg, CH

Dirk Schrijvers profile photo
Dirk Schrijvers

Ziekenhuisnetwerk Antwerpen-Middelheim, Dept. of Medical Oncology, Antwerp, BE

Domen Ribnikar profile photo
Domen Ribnikar

Institute of Oncology Ljubljana, Medical Oncology Dpt., Ljubljana, SI

Douglas Hanahan profile photo
Douglas Hanahan

ISREC- Swiss Institute for Experimental Cancer, Dept. of Life Sciences, Lausanne, CH

Erika Matos profile photo
Erika Matos

Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI

Fatima Cardoso profile photo
Fatima Cardoso

ABC Global Alliance, -, Lisbon, PT

Fatjona Kraja profile photo
Fatjona Kraja

Mother Teresa University Hospital, Oncology Dept., Tirana, AL

Franco Cavalli profile photo
Franco Cavalli

Foundation for the Institute of Oncology Research (IOR), Presidenza, Bellinzona, CH

Frank Jacob profile photo
Frank Jacob

Centre Hospitalier du Nord, Luxembourg, Medical Oncology Department, Ettelbrück, LU

Freddie Bray profile photo
Freddie Bray

International Agency for Research on Cancer, Cancer Surveillance Branch, FR

Guy Berchem profile photo
Guy Berchem

Centre Hospitalier de Luxembourg, Medical Oncology Department, Luxembourg, LU

Ian Tannock profile photo
Ian Tannock

Princess Margaret Hospital, Department of Oncology and Hematology, Toronto, CA

Joseph Gligorov profile photo
Joseph Gligorov

Institut Universitaire de Cancérologie AP-HP Sorbonne Uiversité, Oncologie Médicale site hôpital Tenon, Paris, FR

Lioe-fee De Geus-oei profile photo
Lioe-fee De Geus-oei

Leiden University Medical Center, Nuclear Medicine and Molecular Imaging Department, Leiden, NL

Luzia Travado profile photo
Luzia Travado

Champalimaud Foundation, Champalimaud Clinical and Research Center, Lisbon, PT

Mary Gospodarowicz profile photo
Mary Gospodarowicz

Princess Margaret Cancer Centre - University of Toronto, Dept. of Radiation Oncology, Toronto, CA

Matthias Schuppe profile photo
Matthias Schuppe

European Commission, Luxembourg, LU

Matti Aapro profile photo
Matti Aapro

Clinique de Genolier, Genolier Cancer Center, Genolier, CH

Nikolai Goncharenko profile photo
Nikolai Goncharenko

National Cancer Institute, -, Strassen, LU

Patrick Neven profile photo
Patrick Neven

University Hospitals Leuven, Gynaecologic Oncology, Leuven, BE

Petra Steyerova profile photo
Petra Steyerova

General University Hospital Prague, Clinic of Radiology, Breast Cancer screening and diagnostic center, Prague 2, CZ

Pierfrancesco Franco profile photo
Pierfrancesco Franco

University of Eastern Piedmont, Dept. of Translational Medicine, Novara, IT

Riccardo A. Audisio profile photo
Riccardo A. Audisio

Institute of Clinical Sciences - Sahlgrenska University Hospital, Dept. of Surgery, Göteborg, SE

Silvia Brotea-mosoiu profile photo
Silvia Brotea-mosoiu

Oncology Institute of Bucharest, Medical Oncology Dept., Bucharest, RO

Sophie Servais profile photo
Sophie Servais

University of Luxembourg, Oncology Department, Esch-sur-Alzette, LU

Stefan Bielack profile photo
Stefan Bielack

Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology Dpt., Stuttgart, DE

Stefan Rauh profile photo
Stefan Rauh

Centre Hospitalier Emile Mayrisch Differdange et Esch, Medical Oncology/ Hematology Department, Esch-sur-Alzette, LU

Tanja Cufer profile photo
Tanja Cufer

University of Ljubljana, Medical Faculty, Ljubljana, SI

Urania Dafni profile photo
Urania Dafni

National and Kapodistrian University of Athens, Public Health Dpt., Goudi-Athens, GR

Uta Schmidt-strassburger profile photo
Uta Schmidt-strassburger

Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE

APPLICATIONS ARE CLOSED
 
Participation

The course is open to 60 participants, selected through a competitive application process.

Priority will be given to applicants who have previously attended an ESO–ESMO course for medical students or the ESO–ESSO–ESTRO course for medical students.

 

Who Should Apply

The course is intended for early-career oncologists, in particular Medical or Radiation Oncologists in their first three years of oncology specialisation.

 

How to Apply

Applications must be submitted online 

You will be asked to complete a questionnaire detailing:

  • Your professional and training background
  • Your research experience and publications
  • Your motivation and personal commitment


Required documents (in PDF format):

  • Recommendation letter: Signed and on official hospital letterhead, from your head of department or mentor
  • Curriculum Vitae (CV)


Please ensure all documents are ready before starting the online application. Incomplete submissions will not be considered.


You will be asked to accept ESO’s Data Protection Statement during the application process.

 

Selection Process

Applications are evaluated through a two-step process:

  1. Automated Scoring
    Certain sections of the application are assessed using a predefined points-based system to ensure fairness and consistency.
  2. Committee Review
    Qualitative sections, including motivation and personal statements, are reviewed and scored by ESO’s selection committee.


This dual approach ensures a transparent, balanced and merit-based selection of the most suitable candidates.